Literature DB >> 21960697

Progressive changes in right ventricular geometric shortening and long-term survival in pulmonary arterial hypertension.

Gert-Jan Mauritz1, Taco Kind1, J Tim Marcus2, Harm-Jan Bogaard3, Mariëlle van de Veerdonk1, Pieter E Postmus1, Anco Boonstra1, Nico Westerhof4, Anton Vonk-Noordegraaf5.   

Abstract

BACKGROUND: Until now, many investigators have focused on describing right ventricular (RV) dysfunction in groups of patients with pulmonary arterial hypertension (PAH), but very few have addressed the deterioration of RV function over time. The aim of this study was to investigate time courses of RV geometric changes during the progression of RV failure.
METHODS: Forty-two patients with PAH were selected who underwent right-sided heart catheterization and cardiac MRI at baseline and after 1-year follow-up. Based on the survival after this 1-year run-in period, patients were classified into two groups: survivors (26 patients; subsequent survival of > 4 years) and nonsurvivors (16 patients; subsequent survival of < 4 years). Four-chamber cine imaging was used to quantify RV longitudinal shortening (apex-base distance change), RV transverse shortening (septum-free wall distance change), and RV fractional area change (RVFAC) between end diastole and end systole.
RESULTS: Longitudinal shortening, transverse shortening, and RVFAC measured at the beginning of the run-in period and 1 year later were significantly higher in subsequent survivors than in nonsurvivors (P < .05). Longitudinal shortening did not change during the run-in period in either patient group. Transverse shortening and RVFAC did not change during the run-in period in subsequent survivors but did decrease in subsequent nonsurvivors (P < .05). This decrease was caused by increased leftward septal bowing.
CONCLUSIONS: Progressive RV failure in PAH is associated with a parallel decline in longitudinal and transverse shortening until a floor effect is reached for longitudinal shortening. A further reduction of RV function is due to progressive leftward septal displacement. Because transverse shortening incorporates both free wall and septum movements, this parameter can be used to monitor the decline in RV function in end-stage PAH.

Entities:  

Mesh:

Year:  2011        PMID: 21960697     DOI: 10.1378/chest.10-3277

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  40 in total

Review 1.  Pathobiology of pulmonary arterial hypertension and right ventricular failure.

Authors:  Norbert F Voelkel; Jose Gomez-Arroyo; Antonio Abbate; Harm J Bogaard; Mark R Nicolls
Journal:  Eur Respir J       Date:  2012-06-27       Impact factor: 16.671

Review 2.  Right ventricular adaptation and failure in pulmonary arterial hypertension.

Authors:  John J Ryan; Jessica Huston; Shelby Kutty; Nathan D Hatton; Lindsay Bowman; Lian Tian; Julia E Herr; Amer M Johri; Stephen L Archer
Journal:  Can J Cardiol       Date:  2015-01-29       Impact factor: 5.223

3.  The effects of pulmonary vasodilating agents on right ventricular parameters in severe group 3 pulmonary hypertension: a pilot study.

Authors:  Takahiro Sato; Ichizo Tsujino; Ayako Sugimoto; Toshitaka Nakaya; Taku Watanabe; Hiroshi Ohira; Masaru Suzuki; Satoshi Konno; Noriko Oyama-Manabe; Masaharu Nishimura
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

4.  RV Fractional Area Change and TAPSE as Predictors of Severe Right Ventricular Dysfunction in Pulmonary Hypertension: A CMR Study.

Authors:  Susana Hoette; Nicolas Creuzé; Sven Günther; David Montani; Laurent Savale; Xavier Jaïs; Florence Parent; Olivier Sitbon; Carlos Eduardo Rochitte; Gerald Simonneau; Marc Humbert; Rogerio Souza; Denis Chemla
Journal:  Lung       Date:  2018-02-12       Impact factor: 2.584

5.  Echocardiography Criteria for Structural Heart Disease in Patients With End-Stage Renal Disease Initiating Hemodialysis.

Authors:  LaTonya J Hickson; Sara M Negrotto; Macaulay Onuigbo; Christopher G Scott; Andrew D Rule; Suzanne M Norby; Robert C Albright; Edward T Casey; John J Dillon; Patricia A Pellikka; Sorin V Pislaru; Patricia J M Best; Hector R Villarraga; Grace Lin; Amy W Williams; Vuyisile T Nkomo
Journal:  J Am Coll Cardiol       Date:  2016-03-15       Impact factor: 24.094

Review 6.  Diagnosing and treating the failing right heart.

Authors:  John J Ryan; Ryan J Tedford
Journal:  Curr Opin Cardiol       Date:  2015-05       Impact factor: 2.161

7.  Management of severe pulmonary hypertension in patients undergoing mitral valve surgery.

Authors:  Carlos D Davila; Paul R Forfia
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-06

8.  Bidimensional measurements of right ventricular function for prediction of survival in patients with pulmonary hypertension: comparison of reproducibility and time of analysis with volumetric cardiac magnetic resonance imaging analysis.

Authors:  Celia P Corona-Villalobos; Ihab R Kamel; Neda Rastegar; Rachel Damico; Todd M Kolb; Danielle M Boyce; Ala-Eddin S Sager; Jan Skrok; Monda L Shehata; Jens Vogel-Claussen; David A Bluemke; Reda E Girgis; Stephen C Mathai; Paul M Hassoun; Stefan L Zimmerman
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

Review 9.  State of the art: advanced imaging of the right ventricle and pulmonary circulation in humans (2013 Grover Conference series).

Authors:  Mariëlle C van de Veerdonk; J Tim Marcus; Harm-Jan Bogaard; Anton Vonk Noordegraaf
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

10.  Regional contribution to ventricular stroke volume is affected on the left side, but not on the right in patients with pulmonary hypertension.

Authors:  E Ostenfeld; S S Stephensen; K Steding-Ehrenborg; E Heiberg; H Arheden; G Rådegran; J Holm; M Carlsson
Journal:  Int J Cardiovasc Imaging       Date:  2016-05-03       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.